ABO-102
ABT-003
Phase 2 small_molecule terminated
Quick answer
ABO-102 for MPS IIIA is a Phase 2 program (small_molecule) at ABEONA THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ABEONA THERAPEUTICS INC.
- Indication
- MPS IIIA
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated